pone.0211122.g002.tif (496 kB)

Changes in platelet counts after lusutrombopag therapy and prior to the invasive procedures.

Download (496 kB)
figure
posted on 15.02.2019 by Hitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, Yuka Takahashi, Jun Itakura, Kaoru Tsuchiya, Yutaka Yasui, Nobuharu Tamaki, Kenta Takaura, Yasuyuki Komiyama, Mayu Higuchi, Youhei Kubota, Wann Wang, Mao Okada, Takao Shimizu, Keiya Watakabe, Nobuyuki Enomoto, Namiki Izumi

(A) Patients with baseline platelet count ≤30,000/μL. (B) Patients with baseline platelet count >30,000/μL. (C) Patients with baseline platelet count ≤30,000/μL. Platelet counts in patients with a baseline platelet count ≤30,000/μL were 24±5.9 at baseline which increased to 24±5.9, 28±7.8, 35±8.3, 39±9.8, 43±1.2, and 52±1.6 ×103/μL at 3, 5, 7, 9, 11, and 13 days after administration, respectively. *: p<0.05. (D) Patients with baseline platelet count >30,000/μL. Platelet counts in patients with a baseline platelet count >30,000/μL were 43±8.0 at baseline which increased to 50±1.4, 57±2.1, 64±2.2, 74±2.2, 81±2.5, and 82±2.7 ×103/μL at 3, 5, 7, 9, 11, and 13 days after administration, respectively. *: p<0.05.

History

Licence

Exports